Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
Cadrenal Therapeutics stock last closed at $16.18, down 3.4% from the previous day, and has increased 164.86% in one year. It has overperformed other stocks in the Biotechnology industry by 2.42 percentage points. Cadrenal Therapeutics stock is currently +183.86% from its 52-week low of $5.70, and -29.35% from its 52-week high of $22.90.
At the moment, there are 1.88M shares of CVKD outstanding. The market cap of CVKD is $30.41M. In the past 24 hours, 20,044 CVKD shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy CVKD stock.
In our opinion, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you can buy CVKD today.
Now that you have opened your account on one of the most highly reviewed stock apps, you need to deposit funds:
Watch the tutorial below if you need help transferring money into your new brokerage account.
Once you have selected the best place to buy Cadrenal Therapeutics stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk and upside.
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on CVKD's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CVKD's intrinsic value.
Using relative valuations methods:
You can do additional valuation analysis on CVKD's stock here.
You can dig deeper into what analysts are saying on the Cadrenal Therapeutics stock forecast page.
Over the last 12 months, executives and large shareholders at CVKD have not bought or sold any shares.
Dig into more about who owns CVKD stock here.
No, Cadrenal Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two main order types:
Hit the Open button and your broker will place the order.
If you require additional help with buying stocks on eToro, click the how to video below:
Now that you own some shares in CVKD, you'll want to keep up with your shares.
Add CVKD to a watchlist to see the latest developments about your CVKD stock.
To reiterate, here are the 6 steps for buying Cadrenal Therapeutics stock:
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Cadrenal Therapeutics, click below.